These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7793663)

  • 1. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass.
    Zwissler B; Rank N; Jaenicke U; Schürle B; Welte M; Reichart B; Netz H; Messmer K; Peter K
    Anesthesiology; 1995 Jun; 82(6):1512-6. PubMed ID: 7793663
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
    Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
    Pepke-Zaba J; Higenbottam TW; Dinh-Xuan AT; Stone D; Wallwork J
    Lancet; 1991 Nov; 338(8776):1173-4. PubMed ID: 1682593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children.
    Santos AR; Heidemann SM; Walters HL; Delius RE
    Pediatr Crit Care Med; 2007 Sep; 8(5):465-9. PubMed ID: 17693905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?
    Bush A; Busst C; Booth K; Knight WB; Shinebourne EA
    Circulation; 1986 Jul; 74(1):135-44. PubMed ID: 3518981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
    Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
    Searcy RJ; Morales JR; Ferreira JA; Johnson DW
    Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory pulmonary arterial hypertension with inhaled epoprostenol in an infant with congenital heart disease.
    Kovach J; Ibsen L; Womack M; Steusse D; Law YM
    Congenit Heart Dis; 2007; 2(3):194-8. PubMed ID: 18377465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery.
    Greeley WJ; Bushman GA; Kong DL; Oldham HN; Peterson MB
    J Thorac Cardiovasc Surg; 1988 May; 95(5):842-9. PubMed ID: 3283461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled prostacyclin for the management of pneumonia in a patient with cyanotic heart disease with superior cavo-pulmonary connection.
    Augoustides JG; Abdullah I; Pochettino A; Hanson CW
    Ann Card Anaesth; 2007 Jan; 10(1):51-3. PubMed ID: 17455409
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement.
    Groves DS; Blum FE; Huffmyer JL; Kennedy JL; Ahmad HB; Durieux ME; Kern JA
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):652-60. PubMed ID: 24103713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
    Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Kelleher A; Collins P; Li J; Bush A; Shinebourne EA; Redington AN
    Circulation; 1999 Aug; 100(7):749-55. PubMed ID: 10449698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled NO and prostacyclin during porcine single lung transplantation.
    Vainikka TL; Heikkilä LJ; Kukkonen S; Toivonen HJ
    Ann Thorac Surg; 2001 Dec; 72(6):1892-7. PubMed ID: 11789766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug.
    Corboz MR; Li Z; Malinin V; Plaunt AJ; Konicek DM; Leifer FG; Chen KJ; Laurent CE; Yin H; Biernat MC; Salvail D; Zhuang J; Xu F; Curran A; Perkins WR; Chapman RW
    J Pharmacol Exp Ther; 2017 Dec; 363(3):348-357. PubMed ID: 28904003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.
    Berner M; Beghetti M; Spahr-Schopfer I; Oberhansli I; Friedli B
    Am J Cardiol; 1996 Mar; 77(7):532-5. PubMed ID: 8629600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
    Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
    Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect--anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin.
    von Heymann C; Hagemeyer E; Kastrup M; Ziemer S; Proquitté H; Konertz WF; Spies C
    Pediatr Crit Care Med; 2006 Jul; 7(4):383-5. PubMed ID: 16738494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
    Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ivy DD; Ziegler JW; Kinsella JP; Wiggins JW; Abman SH
    Chest; 1998 Jul; 114(1 Suppl):17S. PubMed ID: 9676605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.